Jane Street Group LLC Raises Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Jane Street Group LLC grew its holdings in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 222.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 130,827 shares of the company's stock after acquiring an additional 90,198 shares during the quarter. Jane Street Group LLC owned about 0.11% of Revvity worth $14,602,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. lifted its position in Revvity by 16.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after buying an additional 2,969,326 shares during the last quarter. Vanguard Group Inc. lifted its position in Revvity by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company's stock worth $1,594,930,000 after buying an additional 156,679 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Revvity by 17.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after buying an additional 1,151,821 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Revvity by 2.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,382,338 shares of the company's stock worth $384,234,000 after buying an additional 69,034 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in Revvity by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 2,901,459 shares of the company's stock worth $322,958,000 after buying an additional 37,666 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on RVTY. JPMorgan Chase & Co. dropped their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Robert W. Baird lowered their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Barclays lowered their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and lowered their price objective for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. Finally, Wells Fargo & Company lowered their price objective on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Trading Down 1.8%

Shares of RVTY traded down $1.68 during mid-day trading on Friday, hitting $91.22. 1,330,339 shares of the company's stock traded hands, compared to its average volume of 938,745. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 1 year low of $88.53 and a 1 year high of $129.50. The firm has a market capitalization of $10.75 billion, a P/E ratio of 41.28, a PEG ratio of 3.82 and a beta of 1.02. The business's 50-day moving average price is $100.83 and its 200-day moving average price is $111.09.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The firm had revenue of $664.76 million for the quarter, compared to analysts' expectations of $662.30 million. During the same period in the previous year, the firm earned $0.98 earnings per share. The business's revenue was up 2.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be paid a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.31%. Revvity's payout ratio is 11.91%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.